FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3763448016 | Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3763449012 | Cytarabine 50 mg/mL suspension for injection | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Is a | Product containing cytarabine (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Pyrimidine analog (substance) | false | Inferred relationship | Some | ||
| Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Cytarabine (substance) | false | Inferred relationship | Some | ||
| Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Has manufactured dose form | injection | false | Inferred relationship | Some | ||
| Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Is a | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Has manufactured dose form | Suspension for injection | true | Inferred relationship | Some | ||
| Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Is a | Cytarabine-containing product in parenteral dose form | false | Inferred relationship | Some | ||
| Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some | ||
| Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Cytarabine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Cytarabine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Has concentration strength numerator value | 50 | false | Inferred relationship | Some | 1 | |
| Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) | This attribute specifies the numerator unit for the concentration strength of a product. | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) | This attribute specifies the denominator unit for the concentration strength of a product. | mL | true | Inferred relationship | Some | 1 | |
| Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Is a | Product containing only cytarabine in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Plays role | Antineoplastic therapeutic role | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets